Data / Form D filings / ImmunityBio, Inc.
ImmunityBio, Inc.: Form D filings
ImmunityBio, Inc., a biotechnology company in San Diego, CA, filed 9 Form D notices with the SEC between 2009 and 2023. The latest, on September 22, 2023, reports $470 million sold of a $470 million offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3530 JOHN HOPKINS COURT, San Diego, CA, 92121
- Phone
- (844) 696-5235
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1326110
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 22, 2023 | New notice | $469,986,600 | $469,986,600 | 3 | Sep 11, 2023 | sec.gov | |
| Jul 22, 2022 | New notice | $10,656,035 | $10,656,035 | 6 | Jul 9, 2022 | sec.gov | |
| Aug 5, 2015 | New notice | $17,000,000 | $17,000,000 | 1 | Jul 31, 2015 | sec.gov | |
| Jul 17, 2015 | Amendment | $78,004,041 | $78,004,041 | 11 | Jun 10, 2015 | sec.gov | |
| Jun 24, 2015 | New notice | $71,004,041 | $71,004,041 | 9 | Jun 10, 2015 | sec.gov | |
| Jan 5, 2015 | New notice | $47,495,481 | $47,495,481 | 1 | Dec 23, 2014 | sec.gov | |
| Dec 29, 2014 | New notice | $10,000,000 | $10,000,000 | 1 | Dec 16, 2014 | sec.gov | |
| Apr 17, 2014 | New notice | $9,600,000 | $6,504,875 | $3,095,125 | 48 | Apr 2, 2014 | sec.gov |
| Oct 9, 2009 | New notice | $500,000 | $425,700 | $74,300 | 14 | Sep 30, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Patrick Soon-Shiong | Executive Officer, Director | |
| Cheryl Cohen | Director | |
| Linda Maxwell | Director | |
| Michael Blaszyk | Director | |
| Wesley Clark | Director | |
| Richard Adcock | Executive Officer, Director | |
| Barry Simon | Director | |
| John Brennan | Director | |
| David Sachs | Executive Officer | |
| Christobel Selecky | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Sep 18, 2023 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what ImmunityBio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.